News | Mobile C-Arms | March 21, 2024

Siemens Healthineers Announces FDA Clearance of CIARTIC Move Self-Driving Mobile C-arm

The new mobile C-arm automates repositioning during surgery

The new mobile C-arm automates repositioning during surgery

March 21, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of the CIARTIC Move, a mobile C-arm with self-driving capabilities. The system accelerates and standardizes 2D fluoroscopic and 3D cone-beam computed tomography (CT) imaging for surgeons and operating room teams in hospitals and outpatient facilities, bringing consistency to automated workflows and reducing imaging time during operations. Designed to address the needs of orthopedic, trauma, and spine surgery, the CIARTIC Move also can be used in thoracic, vascular, cardiovascular, and general surgery, as well as urology and interventional pulmonology.

“With the FDA clearance of the CIARTIC Move, Siemens Healthineers proudly introduces our first self-driving mobile C-arm, which can provide much-needed relief for overtaxed operating room teams by automating and accelerating intraoperative imaging workflows to a previously unseen degree,” said April Grandominico, vice president for surgical therapies in the Advanced Therapies business at Siemens Healthineers North America.

The CIARTIC Move has the potential to address challenges related to intraoperative imaging caused by staff shortages and overloaded surgical teams in the operating room (OR). During many OR procedures, the C-arm must be repositioned frequently to give surgeons the exact anatomical views they need. With conventional mobile C-arms, this repeated manual repositioning can be stressful, time-consuming, and prone to error. The CIARTIC Move is fully motorized from the C-arm down to its wheels, with self-driving capabilities to automate imaging workflows and drive consistency. These automated workflows reduce the time, effort, and workforce capacity required to manually move and position the C-arm. Up to 12 procedure-specific positions can be stored along with related imaging parameters. During a procedure, the stored positions and imaging parameters can be recalled at the touch of a button, without prolonged discussion between the surgeon and OR team. This level of automation helps the surgeon and OR staff easily reproduce images at the desired angle or return the C-arm to park and table positions. Preclinical testing shows significant intraoperative time savings—of almost 50% during spine surgery, for example, and 55% in pelvic surgery, over traditional mobile C-arms.¹ A single user can fully operate the system remotely via a wireless control, even from within the sterile field.

The system can be moved effortlessly due to its fully motorized chassis and touch-sense handles. Active sensing technology protects against collision by scanning for obstacles while in transport mode and stopping all motorized movement if an obstacle is detected.

¹ Data on file

For more information: www.siemens-healthineers.com


Related Content

News | FDA

Dec.1, 2025 – MannKind Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted the sNDA ...

Home December 01, 2025
Home
News | FDA

Nov. 18, 2025 — RapidAI announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the ...

Home November 18, 2025
Home
News | FDA

Nov. 11, 2025 -— Integra LifeSciences Holdings Corp. has announced the FDA 510(k) clearance for use of its CUSA Clarity ...

Home November 18, 2025
Home
News | FDA

Nov. 10, 2025 — Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its latest generation ...

Home November 11, 2025
Home
News | FDA

Oct. 29, 2025 — Circle Cardiovascular Imaging Inc., a provider of cardiovascular imaging solutions, recently announced ...

Home November 03, 2025
Home
News | FDA

Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...

Home October 27, 2025
Home
News | FDA

Oct. 16, 2025 — Thirona recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Home October 16, 2025
Home
News | FDA

Oct. 14, 2025 — Nurea has announced that its PRAEVAorta 2 software has received FDA 510(k) clearance, enabling entry ...

Home October 14, 2025
Home
News | FDA

July 7, 2025 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval to expand the ...

Home July 08, 2025
Home
News | FDA

June 12, 2025 — Viz.ai recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for ...

Home June 12, 2025
Home
Subscribe Now